News
In people with recently diagnosed type 2 diabetes and no prior cardiovascular disease, self-reported physical activity ...
In people with HIV infection, new-onset diabetes is independently predicted by higher leukocyte counts — mostly within the ...
Pfizer Inc. (NYSE:PFE) discovers, develops, markets, and sells biopharmaceutical products in the U.S. and internationally. It ...
Achieve Life Sciences Inc. (NASDAQ:ACHV) is moving closer to a pivotal moment as it seeks FDA approval for cytisinicline, a ...
10h
GlobalData on MSNPadcev-Keytruda combo approved for NHS use in mUC
The combination will now join Bristol Myers Squibb’s Opdivo in the list of bladder cancer drugs available on the NHS.
AI is making an impact in the early stages of drug discovery. It can scan huge chemical and biological datasets, predict how ...
12h
Investor's Business Daily on MSNLow Volatility Calls For This Breakout Trade On Pfizer Stock
Pfizer stock currently trades at very low volatility. That could mean it’s ripe for a breakout trade, like a long strangle.
UCLA’s cancer research has been deeply impactful, with millions of people receiving drugs and therapies developed in Bruin ...
A new treatment regimen for advanced bladder cancer combining MSD's Keytruda with Astellas' Padcev has been given the green ...
The NHS will roll out a new treatment for advanced bladder cancer which doubles survival time. It's estimated that 1,250 ...
A new campaign from AbbVie highlights the “full selves” of people with conditions treated by the company’s therapies, in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results